###begin article-title 0
###xml 23 27 <span type="species:ncbi:10116">Rats</span>
Generation of Knockout Rats with X-Linked Severe Combined Immunodeficiency (X-SCID) Using Zinc-Finger Nucleases
###end article-title 0
###begin p 1
Conceived and designed the experiments: TM BV TS. Performed the experiments: TM AT KY HH TK. Analyzed the data: TM. Wrote the paper: TM.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 13 16 <span type="species:ncbi:10116">rat</span>
###xml 105 108 <span type="species:ncbi:10116">rat</span>
###xml 426 435 <span type="species:ncbi:7955">zebrafish</span>
Although the rat is extensively used as a laboratory model, the inability to utilize germ line-competent rat embryonic stem (ES) cells has been a major drawback for studies that aim to elucidate gene functions. Recently, zinc-finger nucleases (ZFNs) were successfully used to create genome-specific double-stranded breaks and thereby induce targeted gene mutations in a wide variety of organisms including plants, drosophila, zebrafish, etc.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 86 91 86 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 52 55 <span type="species:ncbi:10116">rat</span>
###xml 118 123 <span type="species:ncbi:9606">human</span>
###xml 128 133 <span type="species:ncbi:10090">mouse</span>
We report here on ZFN-induced gene targeting of the rat interleukin 2 receptor gamma (Il2rg) locus, where orthologous human and mouse mutations cause X-linked severe combined immune deficiency (X-SCID). Co-injection of mRNAs encoding custom-designed ZFNs into the pronucleus of fertilized oocytes yielded genetically modified offspring at rates greater than 20%, which possessed a wide variety of deletion/insertion mutations. ZFN-modified founders faithfully transmitted their genetic changes to the next generation along with the severe combined immune deficiency phenotype.
###end p 5
###begin title 6
Conclusions and Significance
###end title 6
###begin p 7
###xml 246 253 246 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 52 56 <span type="species:ncbi:10116">rats</span>
###xml 134 137 <span type="species:ncbi:10116">rat</span>
###xml 148 153 <span type="species:ncbi:9606">human</span>
###xml 188 192 <span type="species:ncbi:10116">rats</span>
The efficient and rapid generation of gene knockout rats shows that using ZFN technology is a new strategy for creating gene-targeted rat models of human diseases. In addition, the X-SCID rats that were established in this study will be valuable in vivo tools for evaluating drug treatment or gene therapy as well as model systems for examining the treatment of xenotransplanted malignancies.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 157 160 157 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Li1">[1]</xref>
###xml 162 165 162 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Buehr1">[2]</xref>
###xml 207 210 207 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Liao1">[3]</xref>
###xml 212 215 212 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Li2">[4]</xref>
###xml 346 349 346 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Voigt1">[5]</xref>
###xml 426 434 426 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 535 538 535 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Ryu1">[6]</xref>
###xml 540 543 540 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Shinohara1">[7]</xref>
###xml 590 598 590 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 678 681 678 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Kitada1">[8]</xref>
###xml 726 729 726 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Zan1">[9]</xref>
###xml 731 735 731 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Smits1">[10]</xref>
###xml 1157 1161 1157 1161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Mashimo1">[11]</xref>
###xml 1163 1167 1163 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Yoshimi1">[12]</xref>
###xml 1489 1493 1489 1493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Mashimo1">[11]</xref>
###xml 101 106 <span type="species:ncbi:10090">mouse</span>
###xml 139 142 <span type="species:ncbi:10116">rat</span>
###xml 144 147 <span type="species:ncbi:10116">Rat</span>
###xml 351 354 <span type="species:ncbi:10116">Rat</span>
###xml 800 803 <span type="species:ncbi:10116">rat</span>
Although several strategies are available for producing a wide variety of genomic alterations in the mouse, the same cannot be said of the rat. Rat ES cells [1], [2] and induced pluripotent stem cells (iPS) [3], [4] are available, but the culture conditions for these cells and the methodology for inducing homologous recombination are imperfect [5]. Rat spermatogonial stem cells (SSC) have also been isolated and cultivated in vitro but their yield proved unsatisfactory in terms of their ability to undergo homologous recombination [6], [7]. Besides these methods which are based on the in vitro genetic engineering of pluripotent stem cells, transposon-mediated mutagenesis [8] and N-ethyl-N-nitrosourea (ENU) mutagenesis [9], [10] have been used with some success for producing mutations in the rat genome. We recently reported on a high-throughput gene-driven strategy which uses the mutagen ENU and the Mu-transposition reaction (MuT-POWER) to rapidly detect induced mutations. This was in addition to our investigation of intracytoplasmic sperm injection (ICSI) for recovering heterozygous genotypes of interest out of a large sperm cell repository [11], [12]. However, even if a large number of mutant strains already exists or may potentially be available, targeted modification or disruption of specific DNA regions is difficult to achieve. Even in the case of our gene-driven strategy, X-linked mutations are impossible to obtain because of the breeding protocol which is used [11].
###end p 9
###begin p 10
###xml 135 157 135 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Caenorhabditis elegans</italic>
###xml 214 218 214 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Porteus1">[13]</xref>
###xml 220 224 220 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Wu1">[14]</xref>
###xml 226 230 226 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Hockemeyer1">[15]</xref>
###xml 437 440 437 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fok</italic>
###xml 999 1003 999 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Geurts1">[16]</xref>
###xml 1174 1179 1174 1179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 1425 1429 1425 1429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Noguchi1">[17]</xref>
###xml 1431 1435 1431 1435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Leonard1">[18]</xref>
###xml 1849 1854 1849 1854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prkdc</italic>
###xml 1860 1864 1860 1864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Blunt1">[19]</xref>
###xml 1866 1870 1866 1870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Kirchgessner1">[20]</xref>
###xml 1875 1880 1875 1880 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 1893 1897 1893 1897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Cao1">[21]</xref>
###xml 1899 1903 1899 1903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-DiSanto1">[22]</xref>
###xml 1905 1909 1905 1909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Ohbo1">[23]</xref>
###xml 1911 1916 1911 1916 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 135 157 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
###xml 178 187 <span type="species:ncbi:7955">zebrafish</span>
###xml 193 198 <span type="species:ncbi:9606">human</span>
###xml 825 828 <span type="species:ncbi:10116">rat</span>
###xml 1414 1419 <span type="species:ncbi:9606">human</span>
###xml 1526 1531 <span type="species:ncbi:10090">mouse</span>
###xml 1632 1635 <span type="species:ncbi:10116">rat</span>
###xml 1659 1664 <span type="species:ncbi:10090">mouse</span>
###xml 1888 1892 <span type="species:ncbi:10090">mice</span>
###xml 1924 1928 <span type="species:ncbi:10116">rats</span>
Recently, a novel gene-targeting technology which employs zinc-finger nucleases (ZFNs) has been proven to work successfully in plants, Caenorhabditis elegans, frogs, drosophila, zebrafish, and human ESCs and iPSCs [13], [14], [15]. ZFNs are chimeric proteins that consist of a specific DNA-binding domain which is made of tandem zinc finger-binding motifs that are fused to a non-specific cleavage domain of the restriction endonuclease FokI. ZFNs can create site-specific double-stranded breaks which are repaired via non-homologous end joining (NHEJ), a process that results in the arbitrary addition or deletion of base pairs. Consequently, repair by NHEJ is mutagenic and results in a knockout. Recently, it was reported that a single injection of DNA or messenger RNA that encodes specific ZFNs into one-cell transgenic rat embryos that express GFP could lead to a high frequency of animals that do not express the transgenic marker as a consequence of homologous recombination at the GFP site [16]. Here, we report on an experiment that involved using ZFN technology. The aim of the experiment was to inactivate the gene that encodes the interleukin 2 receptor gamma (Il2rg), which is essential for signaling by interleukins such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. In addition, the gene is involved in the X-linked form of severe combined immunodeficiency (X-SCID), one of the most common forms of human SCID [17], [18]. A major motivation for performing this experiment was the observation that although SCID mouse animal models are the most commonly used in research on drug development, an X-SCID immunodeficient rat model would complement mouse models through the additional advantage of being employed for testing the pharmacodynamics and toxicity of potential therapeutic compounds. Following the results of research involving Prkdc SCID [19], [20] and Il2rg X-SCID mice [21], [22], [23], Il2rg X-SCID rats should have a very low level of NK cell activity and thereby make xenotransplantation more successful.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
###xml 13 18 13 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 42 45 <span type="species:ncbi:10116">rat</span>
Injection of Il2rg ZFN-encoding mRNA into rat embryos
###end title 12
###begin p 13
###xml 185 197 185 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008870-g001">Figure 1a, b</xref>
###xml 202 209 202 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008870-t001">Table 1</xref>
###xml 476 485 476 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008870-g001">Figure 1c</xref>
###xml 490 499 490 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008870.s001">Figure S1</xref>
###xml 576 581 576 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 1167 1176 1167 1176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008870-g001">Figure 1d</xref>
###xml 1351 1360 1351 1360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008870-g001">Figure 1e</xref>
###xml 101 105 <span type="species:ncbi:10116">rats</span>
Of 443 ZFN-injected embryos, 230 (51.9%) were transferred into the oviducts of pseudopregnant female rats, and 54 (24.3%) of these embryos were successfully carried to term as shown in Figure 1a, b and Table 1. Sequence analysis of the ZFN target site of these 54 founder animals revealed that 5 males and 8 females (24.1%) carried a variety of mutations including from 3 to1,097 bp deletions and a 1 bp insertion in the region which overlapped the ZFN target site as seen in Figure 1c and Figure S1. Four out of five of the males carried different biallelic mutations at the Il2rg locus despite them only having one X chromosome. This suggests that mosaicism was induced by the ZFN treatment, a situation which is frequently observed in the DNA of transgenic founders. Three of the affected females had a monoallelic homozygous mutation, four had heterologous or mosaicism biallelic mutations, and the remainder had three different mosaic mutations. The normal F344-allele was not found in the affected founder animals. Most of these mutations were expressed as frameshifts or splicing errors and resulted in no or very little IL2RG mRNA being expressed as shown in Figure 1d probably due to nonsense-mediated decay. Western blotting with antibodies against the C-terminal domain of IL2RG did not reveal any protein in the founder animals as seen in Figure 1e.
###end p 13
###begin title 14
###xml 13 18 13 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 42 45 <span type="species:ncbi:10116">rat</span>
Injection of Il2rg ZFN-encoding mRNA into rat embryos induced targeted loss-of-function mutations.
###end title 14
###begin p 15
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 274 283 274 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008870.s004">Figure S4</xref>
###xml 452 457 452 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 36 39 <span type="species:ncbi:10116">rat</span>
###xml 385 388 <span type="species:ncbi:10116">rat</span>
###xml 722 726 <span type="species:ncbi:10116">rats</span>
###xml 869 873 <span type="species:ncbi:10116">rats</span>
###xml 1000 1004 <span type="species:ncbi:10116">rats</span>
(a) Schematic representation of the rat Il2rg gene. Exons are represented as blue boxes. Regions used to design the ZFN templates are printed in red for the left ZFN and green for the right ZFN. The magnified views illustrate the binding sites for the ZFN pairs. Please see Figure S4 for further details. (b) Schematic representation of the method used for ZFN-targeted mutagenesis in rat embryos. (c) Sequencing assay for ZFN-induced mutations in the Il2rg-targeted region. Multiple deletions or insertions depicted using red dashes or letters, respectively, are aligned along the wild-type sequences shown on the top line. (d) RT-PCR analysis of IL2RG mRNA expression in the spleen of control F344, founder (G0), and G1 rats. GAPDH expression was used as an internal control. (e) Western blotting for IL2RG protein in the spleen of control F344, founder (G0), and G1 rats. beta-actin was used as a loading control. (f) ELISA for serum IgG, IgA, and IgM levels in control F344, founder (G0), and G1 rats. *P<0.01, **P<0.001, and ***P<0.0001, indicated for each group in comparison with control F344 for independent sample Student t-tests.
###end p 15
###begin title 16
Injection of ZFN-encoding mRNA into fertilized oocytes.
###end title 16
###begin p 17
Injected oocytes were cultured in KRB overnight and cryopreserved at the two-cell stage.
###end p 17
###begin p 18
###xml 235 243 235 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008870.s005">Table S1</xref>
To clarify whether the ZFNs only induced mutations in the targeted region, we checked 16 sites that showed a high rate of similarity with the targeted site at the sequence level with no more than 6 to 7 bp mismatches as illustrated in Table S1. Insertions or deletions were not observed at any of these off-target sites among the 13 ZFN-modified founders. This confirms that ZFNs can be reliably and efficiently used to produce mutant alleles at loci of interest. Although we cannot exclude the possibility that the ZFNs may have cleaved unknown off-target sites, such undesired mutations can subsequently be easily excluded from the genome of the carrier animals by backcrossing to the parental strain or another background strain.
###end p 18
###begin title 19
Germ line transmission of ZFN-modified genetic changes
###end title 19
###begin p 20
###xml 165 173 165 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008870.s006">Table S2</xref>
###xml 881 890 881 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008870.s002">Figure S2</xref>
To assess the transmission of ZFN-modified genetic changes to the next generation, we crossed the founder animals with the background strain F344/Stm as depicted in Table S2. All 38 offspring consisting of 18 males and 20 females that were obtained from the founder females mated with the F344 males had one of the maternal mutations. This indicates that ZFN-induced mutations were faithfully transmitted through the germ line. In the offspring that were obtained from the founder males, there were two cases where only one of the paternal bialleles was transmitted or both alleles were transmitted. This suggests that mosaicism occurred not only in somatic cells but also in the germ line of the founder animals. PCR analysis of genomic DNA isolated from several types of tissues indicated that somatic mosaicism occurred in the progenitors but not in their offspring as shown in Figure S2.
###end p 20
###begin p 21
###xml 66 67 66 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 61 69 61 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg<sup>&#8722;</sup>/Y</italic>
###xml 100 101 100 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 107 108 107 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 95 108 95 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg<sup>&#8722;</sup>/Il2rg<sup>&#8722;</sup></italic>
###xml 149 157 149 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008870.s007">Table S3</xref>
###xml 325 334 325 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008870-g002">Figure 2a</xref>
###xml 458 463 458 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 484 497 484 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008870-g001">Figures 1d, e</xref>
###xml 632 641 632 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008870-g001">Figure 1f</xref>
###xml 219 223 <span type="species:ncbi:10116">rats</span>
###xml 393 397 <span type="species:ncbi:10116">rats</span>
###xml 615 619 <span type="species:ncbi:10116">rats</span>
We intercrossed the G0 founders to produce hemizygous males (Il2rg-/Y) and homozygous females (Il2rg-/Il2rg-) for the ZFN-induced mutation listed in Table S3 to characterize the immunodeficient phenotypes of the X-SCID rats. The hemizygous males and homozygous females appeared normal at birth and developed well as shown in Figure 2a. RT-PCR and Western blot assays was performed on these G1 rats and the results showed a complete loss of expression of the Il2rg gene as detailed in Figures 1d, e. ELISA for serum immunoglobulin (Ig) levels revealed reduced IgG, diminished IgA, and increased IgM levels in the G1 rats as noted in Figure 1f.
###end p 21
###begin title 22
###xml 40 44 <span type="species:ncbi:10116">rats</span>
Abnormal lymphoid development in X-SCID rats.
###end title 22
###begin p 23
###xml 50 51 50 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 45 53 45 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg<sup>&#8722;</sup>/Y</italic>
###xml 65 68 65 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/Y</italic>
###xml 70 74 <span type="species:ncbi:10116">rats</span>
###xml 106 110 <span type="species:ncbi:10116">rats</span>
###xml 142 146 <span type="species:ncbi:10116">rats</span>
###xml 222 226 <span type="species:ncbi:10116">rats</span>
###xml 253 256 <span type="species:ncbi:10116">rat</span>
###xml 401 405 <span type="species:ncbi:10116">rats</span>
(a) Photograph of five week-old male X-SCID (Il2rg-/Y) and F344 (+/Y) rats. (b) Thymus of X-SCID and F344 rats. (c) Spleen of X-SCID and F344 rats. (d, e) Histological analysis of the thymus of X-SCID (X40) and F344 (X40) rats. The thymus of the X-SCID rat was severely hypoplastic and consisted of an epithelial cell sheet. (f, g) Histological analysis of the spleen of X-SCID (X100) and F344 (X100) rats. In the X-SCID spleen, the white pulp was virtually devoid of lymphocytes and the red pulp was occupied by a variety of myeloid elements. (h) Dot plots representing CD3, CD45RA and CD161a for differentiation of T-, B- and NK cell sub-populations, and CD3, CD4 and CD8 for demarcation of T-cell sub-populations in peripheral blood lymphocyte cells. The numbers shown in the quadrants are mean percentages. The circled areas indicate cell populations that are referred to in the text.
###end p 23
###begin title 24
###xml 20 26 20 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg-</italic>
###xml 43 47 <span type="species:ncbi:10116">rats</span>
Characterization of Il2rg-deficient X-SCID rats
###end title 24
###begin p 25
###xml 135 143 135 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008870-g002">Figure 2</xref>
###xml 208 217 208 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008870-g002">Figure 2b</xref>
###xml 293 302 293 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008870-g002">Figure 2d</xref>
###xml 360 369 360 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008870-g002">Figure 2c</xref>
###xml 468 477 468 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008870-g002">Figure 2f</xref>
###xml 698 706 698 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008870.s008">Table S4</xref>
###xml 797 805 797 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008870.s009">Table S5</xref>
###xml 981 990 981 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008870-g002">Figure 2h</xref>
###xml 995 1004 995 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008870.s003">Figure S3</xref>
###xml 1023 1024 1023 1024 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1027 1028 1027 1028 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1082 1083 1082 1083 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1086 1087 1086 1087 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1187 1188 1187 1188 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1194 1195 1194 1195 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1211 1212 1211 1212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1218 1219 1218 1219 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 75 79 <span type="species:ncbi:10116">rats</span>
###xml 166 170 <span type="species:ncbi:10116">rats</span>
###xml 678 682 <span type="species:ncbi:10116">rats</span>
###xml 791 795 <span type="species:ncbi:10116">rats</span>
Gross and microscopic analyses at five weeks of age showed that the X-SCID rats underwent abnormal lymphoid development as depicted in Figure 2. The thymus of X-SCID rats was extremely hypoplastic as seen in Figure 2b and consisted of an epithelial rudiment without any lymphocytes as seen in Figure 2d. The spleen was moderately decreased in size as noted in Figure 2c, and the white pulp was severely hypoplastic and the red pulp contained myeloid cells as shown in Figure 2f. Peripheral lymph nodes and Peyer's patches were not identified by necropscopy. In the peripheral blood (PB) profiles, the numbers of white blood cells (WBCs) was reduced compared to those of control rats as detailed in Table S4. Differential counts of WBCs showed a dramatic decrease in leukocytes in the X-SCID rats (Table S5). Flow cytometry analysis of cell populations isolated from PB, bone marrow (BM), and the spleen also revealed a dramatic decrease in the number of the lymphocytes as seen in Figure 2h and Figure S3. The number of CD4-CD8+ T-cells was markedly diminished and the number of CD4+CD8- T-cells was decreased although some cells were present in PB, BM and the spleen. The numbers of CD3-CD45RA+ B-cells and CD3-CD161a+ NK cells were markedly diminished in PB and BM, but some cells were present in the spleen. Heterozygous females exhibited normal lymphoid development and were indistinguishable from normal control females (data not shown).
###end p 25
###begin title 26
###xml 23 28 <span type="species:ncbi:9606">human</span>
Xenotransplantation of human tumor cells
###end title 26
###begin p 27
###xml 200 204 200 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Cao1">[21]</xref>
###xml 206 210 206 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-DiSanto1">[22]</xref>
###xml 212 216 212 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Ohbo1">[23]</xref>
###xml 318 323 318 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 568 580 568 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008870-g003">Figure 3a, b</xref>
###xml 648 657 648 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008870-g003">Figure 3c</xref>
###xml 47 51 <span type="species:ncbi:10116">rats</span>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
###xml 231 235 <span type="species:ncbi:10090">mice</span>
###xml 300 306 <span type="species:ncbi:9606">humans</span>
###xml 334 338 <span type="species:ncbi:10116">rats</span>
###xml 376 381 <span type="species:ncbi:9606">human</span>
###xml 421 425 <span type="species:ncbi:10116">rats</span>
###xml 519 523 <span type="species:ncbi:10116">rats</span>
###xml 712 717 <span type="species:ncbi:9606">human</span>
###xml 837 841 <span type="species:ncbi:10116">rats</span>
These immunodeficient phenotypes of the X-SCID rats were very similar to those of the previously reported X-SCID mice and were characterized by a nearly complete lack of T-cells, B-cells and NK cells [21], [22], [23]. Since X-SCID mice cannot reject transplanted tissues from other species including humans, we tested Il2rg-deficient rats as a host for xenotransplantation of human ovarian cancer tumor cells. All X-SCID rats developed tumors within 14 days after injection of the cells (6/6, 100%), while control F344 rats showed no tumor growth (0/6, 0%) as seen in Figure 3a, b. The tumors were confirmed by histological analysis as depicted in Figure 3c and by PCR with primers that were used to amplify the human MHC class II DQB2 region (data not shown). These observations illustrate the impaired immune system function of X-SCID rats and suggest that the animals may be important models for cancer and transplantation research.
###end p 27
###begin title 28
###xml 50 55 <span type="species:ncbi:9606">human</span>
Tumor development from the xenotransplantation of human ovarian cancer cells.
###end title 28
###begin p 29
###xml 76 81 <span type="species:ncbi:9606">human</span>
###xml 122 126 <span type="species:ncbi:10116">rats</span>
###xml 293 297 <span type="species:ncbi:10116">rats</span>
###xml 314 318 <span type="species:ncbi:10116">rats</span>
###xml 387 391 <span type="species:ncbi:10116">rats</span>
(a) Growth curve of tumor development after subcutaneous injection of A2780 human ovarian cancer cells in F344 and X-SCID rats. *P<0.01, **P<0.001, and ***P<0.0001, indicated in comparison with control F344. (b) The tumors became large and grew quickly about 11 days after injection in X-SCID rats but not in F344 rats. (c) Histology of the xenotransplanted tumors that formed in X-SCID rats (X400). No lymphocytic infiltration was detected in the tumors.
###end p 29
###begin title 30
Discussion
###end title 30
###begin p 31
###xml 1437 1441 1437 1441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Hockemeyer1">[15]</xref>
###xml 1443 1447 1443 1447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Urnov1">[24]</xref>
###xml 1449 1453 1449 1453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Kandavelou1">[25]</xref>
###xml 154 158 <span type="species:ncbi:10116">rats</span>
###xml 189 193 <span type="species:ncbi:10116">rats</span>
###xml 344 348 <span type="species:ncbi:10090">mice</span>
###xml 1564 1567 <span type="species:ncbi:10116">rat</span>
###xml 1744 1748 <span type="species:ncbi:9823">pigs</span>
###xml 1750 1756 <span type="species:ncbi:9913">cattle</span>
In this study, we proved that targeted gene disruption using ZFN technology works well and provides for several advantages and possibilities when used in rats. First and foremost, knockout rats can be created in a four- to six-month time frame and with high efficiency at more than 20%. This is more favorable than the ES cell-based method for mice that usually takes 12-18 months. Given the high rate of germ line transmission, preliminary phenotypic analysis can be performed on G1 animals after intercrossing the initial G0 founders, thereby saving time and effort. Second, gene-targeting with ZFNs does not seem to be strain-dependent (unpublished data) and accordingly can be performed with any inbred strain. This is of great advantage since other techniques like ENU mutagenesis differ in their efficiency when used with different strains. This provides a straight forward strategy for directly employing targeted gene disruption in the existing strain, thereby bypassing tedious and time-consuming backcrossing steps that generally take two to three years to complete. Third, ZFNs can be used to induce a wide variety of allelic changes covering small or wide deletions or insertions. They may be used to produce frameshifts or small in-frame deletions such as the 3-bp deletion that we observed. Given the reports on successful ZFN-targeted gene modification or correction by homologous recombination in mammalian cell cultures [15], [24], [25], it should be feasible to archive targeted knock-in technologies that have thus been far inaccessible without rat ES cells. Finally, since ZFN technology does not rely on using species-specific embryonic stem cell lines, it should be possible to adapt it to other mammalian species such as pigs, cattle, and monkeys, where it is possible to harvest and manipulate fertilized embryos.
###end p 31
###begin p 32
###xml 70 77 70 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 300 307 300 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 390 394 390 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Dao1">[26]</xref>
###xml 396 400 396 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Thomsen1">[27]</xref>
###xml 402 406 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Shultz1">[28]</xref>
###xml 444 449 444 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 455 460 455 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prkdc</italic>
###xml 755 759 755 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Ito1">[29]</xref>
###xml 761 765 761 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Quintana1">[30]</xref>
###xml 767 771 767 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Machida1">[31]</xref>
###xml 11 15 <span type="species:ncbi:10116">rats</span>
###xml 322 327 <span type="species:ncbi:9606">human</span>
###xml 424 428 <span type="species:ncbi:10090">mice</span>
###xml 558 563 <span type="species:ncbi:9606">human</span>
###xml 587 592 <span type="species:ncbi:9606">human</span>
###xml 659 664 <span type="species:ncbi:9606">human</span>
###xml 783 787 <span type="species:ncbi:10116">rats</span>
The X-SCID rats established in this study provide not only a valuable in vivo model for evaluating drug treatment or gene therapy approaches, but also a system for assaying novel anticarcinogenic effects on transplanted malignancies. There is a growing need for animal models with which to carry out in vivo studies using human cells, tissues or organs as chimeras such as humanized models [26], [27], [28]. X-SCID and SCID mice homozygous for Il2rg- and Prkdc- alleles with a non-obese diabetic background are a powerful tool for the xenotransplantation of human tissues or potentially human ES/iPS cells. This could lead to advances in our understanding of human hematopoiesis, immunology, cancer biology, infectious diseases, and regenerative medicine [29], [30], [31]. Humanized rats, if generated by ZFN technology, could be powerful tools for pre-clinical testing during drug development and be better models in various fields of translational research.
###end p 32
###begin title 33
Materials and Methods
###end title 33
###begin title 34
Animals
###end title 34
###begin p 35
###xml 187 193 187 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1Kyo</sup>
###xml 181 193 181 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rgt<sup>tm1Kyo</sup></italic>
###xml 201 205 <span type="species:ncbi:10116">rats</span>
###xml 265 268 <span type="species:ncbi:10116">Rat</span>
All animal care and experiments conformed to the Guidelines for Animal Experiments of Kyoto University, and were approved by the Animal Research Committee of Kyoto University. F344-Il2rgttm1Kyo X-SCID rats are deposited at the National Bio Resource Project for the Rat in Japan ().
###end p 35
###begin title 36
ZFN constructs
###end title 36
###begin p 37
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 166 170 166 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Doyon1">[32]</xref>
###xml 260 264 260 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Doyon1">[32]</xref>
###xml 266 270 266 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Santiago1">[33]</xref>
###xml 743 747 743 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008870-Miller1">[34]</xref>
###xml 859 864 859 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 882 891 882 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008870.s004">Figure S4</xref>
###xml 38 41 <span type="species:ncbi:10116">rat</span>
Custom-designed ZFNs plasmids for the rat Il2rg gene were obtained from Sigma-Aldrich. The design, cloning, and validation of the ZFNs was performed by Sigma-Aldrich [32]. ZFN design involved using an archive of pre-validated two-finger and one-finger modules [32], [33]. The target region was scanned for positions where modules exist in the archive. This allowed the fusion of two or three such molecules to generate a five-finger protein that recognizes a 15 bp site on the top strand and the fusion of two to three different modules that recognize a 15 bp site on the bottom strand that lies 5-6 bp away. Measurements of ZFNs for gene disruption activity were performed using the Surveyor endonuclease (CEL-1) assay as described elsewhere [34]. Final candidate ZFNs were designed to recognize a site within the boundary between exon 2 and intron 2 of the Il2rg gene as shown in Figure S4.
###end p 37
###begin title 38
Microinjection of ZFN mRNA
###end title 38
###begin p 39
###xml 75 78 75 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xho</italic>
###xml 171 179 171 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1004 1005 967 968 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
To prepare ZFN mRNA, ZFN-encoding expression plasmids were linearized with XhoI and extracted with phenol-chloroform by the standard method. Messenger RNA was transcribed in vitro using a MessageMaxtrade mark T7 mRNA transcription kit (Epicentre) and polyadenylated using a A-Plustrade mark Poly(A) polymerase tailing kit (Epicentre). The resulting mRNA was purified using a MEGACleartrade mark kit (Epicentre) and finally resuspended in RNase-free water at 10 ng/microl for each ZFN. Approximately 2-3 pL of capped mRNA were injected into the male pronuclei of zygotes by the same method that was used to microinject DNA. Pronuclear stage embryos were collected from F344/Stm and TM/Kyo females six weeks of age that had been super-ovulated by injecting them with eCG (Serotropin, Asuka Pharmaceutical Co.) and hCG (Gonatropin, Asuka Pharmaceutical Co.). They were mated with males of the same respective strain. The mRNA solution was injected and embryos were cultured in KRB at 37.5degreesC with 5% CO2 and 95% humidified air to promote their recovery. The embryos that survived were transferred to the oviduct of pseudopregnant females (Crlj:WI, 8-12wks).
###end p 39
###begin title 40
Analysis of genome editing at ZFN target sites
###end title 40
###begin p 41
###xml 454 455 422 423 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Genomic DNA was extracted from the tail, brain, heart, and liver using a GENEXTRACTOR TA-100 automatic DNA purification system (Takara). PCR for each was carried out in a total volume of 15 microl under the following conditions for 35 cycles: 94degreesC for 3 min for 1 cycle, 94degreesC for 30 sec, 60degreesC for 30 sec, and 72degreesC for 1 min. The final reaction mixture for each contained 100 ng of genomic DNA, 200 microM of each dNTP, 1.0 mM MgCl2, 0.66 microM of each primer, and 0.4 U of Taq DNA polymerase (GibcoBRL).
###end p 41
###begin p 42
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 181 190 181 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008870.s004">Figure S4</xref>
For editing the ZFN cleavage site in the genome at the Il2rg locus, three primer sets were designed to amplify small 292-bp, middle 1509-bp, and large 3158-bp fragments as shown in Figure S4. The PCR products were directly sequenced using the BigDye terminator v3.1 cycle sequencing mix and the standard protocol for an Applied Biosystems 3130 DNA Sequencer. The products were also subcloned into the pCR4-TOPO vector (Invitrogen), and plasmid DNA was prepared and sequenced on a 3130 DNA Sequencer. All new sequence data is deposited in GenBank (GU294902-GU294925).
###end p 42
###begin title 43
Off-target site analysis
###end title 43
###begin p 44
###xml 256 263 256 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008870-t001">Table 1</xref>
###xml 336 344 336 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008870.s010">Table S6</xref>
###xml 88 91 <span type="species:ncbi:10116">rat</span>
Off-target sites with the highest degree of similarity were identified by searching the rat genome (RGSCv3.4) for matches with the consensus sequence of each ZFP with appropriate spacing of 5-6 bp. A list of these target sites is provided in Supplementary Table 1. PCR primers were designed to flank the off-target sites as detailed in Table S6. Reactions were performed for the founder animals and the PCR products were directly sequenced on the 3130 DNA Sequencer.
###end p 44
###begin title 45
RT-PCR and Western blotting
###end title 45
###begin p 46
###xml 321 326 317 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 340 349 336 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008870.s004">Figure S4</xref>
###xml 363 368 359 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gapdh</italic>
###xml 368 397 364 393 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GGCACAGTCAAGGCTGAGAATG-3&#8242;</named-content>
###xml 402 429 398 425 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATGGTGGTGAAGACGCCAGTA-3&#8242;</named-content>
###xml 92 96 <span type="species:ncbi:10116">rats</span>
###xml 521 525 <span type="species:ncbi:10116">rats</span>
###xml 596 599 <span type="species:ncbi:10116">rat</span>
Total RNA was extracted using Isogen reagent (Nippon Gene) from the spleen of five week-old rats. First strand cDNA was synthesized from 5 microg of total RNA that had been treated using DNase by using the oligo(dT)12-18 primer and SuperscriptII reverse transcriptase (Invitrogen). PCR was performed with the primers for Il2rg described in Figure S4 and with the Gapdh5'- GGCACAGTCAAGGCTGAGAATG-3' and 5'-ATGGTGGTGAAGACGCCAGTA-3'. Western blotting was carried out using the cell lysates from the spleens of five week-old rats by the standard method. Signals were detected with antibodies against rat IL2RG (M-20, Santa Cruz Biotechnology) and beta-actin (AC-40, Sigma Aldrich).
###end p 46
###begin title 47
Immunofluorescence and histological analyses
###end title 47
###begin p 48
###xml 65 71 65 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg-</italic>
###xml 111 115 <span type="species:ncbi:10116">rats</span>
###xml 284 287 <span type="species:ncbi:10116">Rat</span>
Complete necroscopy examinations were performed on five week-old Il2rg-deficient and wild-type male and female rats. Peripheral blood specimens were collected from the caudal vena cava. Serum immunoglobulin (Ig) levels were measured by enzyme-linked immunosorbent assay (ELISA) using Rat IgG, IgA and IgM ELISA Quantitation kits (Bethyl Laboratories). Blood parameters for a complete blood cell count, a WBC differential, and a reticulocyte count were measured using ADVIA 2120 flow cytometry (Block Scientific). For histopathology, tissues were fixed in Bouin's fluid and embedded in paraffin. The embedded tissues were then sectioned at 5-7 microm thickness at room temperature and stained with hematoxylin and eosin to permit evaluation by light microscopy.
###end p 48
###begin p 49
###xml 139 142 <span type="species:ncbi:10116">Rat</span>
###xml 259 262 <span type="species:ncbi:10116">Rat</span>
###xml 450 455 <span type="species:ncbi:10090">Mouse</span>
Flow cytometric analyses of cell populations isolated from bone marrow, the spleen and peripheral blood were carried out using IOTest Anti-Rat CD3-FITC/CD45RA-PC7/CD161a-APC (Beckman Coulter) to differentiate T-, B- and NKcell sub-populations and IOTest Anti-Rat CD3-FITC/CD4-PC7/CD8-APC (Beckman Coulter) to enumerate T-cell sub-populations. Anti-CD45 monoclonal antibodies (Beckman Coulter) were used for the intracellular staining of lymphocytes. Mouse IgM, IgG1 and IgG2a antibodies (Beckman Coulter) were used as isotype-matched controls. The cell samples were treated with FcR-blocking reagent (Miltenyi Biotec) for 10 minutes, stained with the fluorochrome-conjugated antibodies for 30 minutes, and washed three times with PBS/10% FCS. Stained cell samples were analyzed with a four-color FACS flow cytometer (FACSCalibur, Becton Dickinson) using CellQuest software (Becton Dickinson).
###end p 49
###begin title 50
Tumor cell xenotransplantation
###end title 50
###begin p 51
###xml 229 230 229 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 353 354 353 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 367 368 367 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 420 421 420 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 469 470 469 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 473 475 473 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ab</italic>
###xml 475 476 475 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 486 487 486 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 665 691 665 691 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCTAGGGTGGTCAGACTGGA-3&#8242;</named-content>
###xml 696 722 696 722 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AAAATCCCCCAAAACAAAGG-3&#8242;</named-content>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 315 319 <span type="species:ncbi:10116">rats</span>
###xml 528 533 <span type="species:ncbi:9606">Human</span>
The human ovarian cancer cell line A2780 was purchased from the European Collection of Cell Cultures (ECACC). Cells were cultured in RPMI1640 medium (GIBCO) with 10% heat-inactivated FBS (Hyclone). Subcutaneous injections of 2x105 A2780 cells with Matrigel (Becton Dickinson) were performed on five week-old female rats. Tumors were measured by length (a) and width (b) in millimeters using calipers, and tumor volumes (V) were calculated according to the relationship V = ab2/2, where a was the longer of the two measurements. Human-specific PCR primers were designed to amplify major histocompatibility complex class II DQ beta 2 (HLA-DQB2) at exon 4 as follows: 5'-CCTAGGGTGGTCAGACTGGA-3' and 5'-AAAATCCCCCAAAACAAAGG-3'.
###end p 51
###begin title 52
Supporting Information
###end title 52
###begin p 53
###xml 130 135 130 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 268 277 268 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008870.s004">Figure S4</xref>
###xml 401 404 399 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hae</italic>
PCR analysis of 13 mutant founders for the zinc-finger nuclease (ZFN) target site. For the analysis of the ZFN target site at the Il2rg locus, three primer sets were used to amplify small (a, 292-bp), middle (b, 1509-bp), and large (c, 3158-bp) fragments for PCR. See Figure S4 for further details. PCR fragments were electrophoresed through a 1-4% agarose gel. M: DNA molecular weight marker phiX174-HaeIII digest.
###end p 53
###begin p 54
(9.19 MB TIF)
###end p 54
###begin p 55
Click here for additional data file.
###end p 55
###begin p 56
###xml 184 193 184 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008870.s004">Figure S4</xref>
###xml 484 487 482 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hae</italic>
###xml 512 516 510 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hind</italic>
###xml 376 380 <span type="species:ncbi:10116">rats</span>
PCR analysis of genomic DNA isolated from several tissues. Three primer sets were used to amplify small (a, 292-bp), middle (b, 1509-bp), and large (c, 3158-bp) fragments for PCR. See Figure S4 for further details. Genomic DNA (T: tail, B: brain, H: heart, L: liver) was used as a template for PCR in zinc-finger nuclease-modified founders (numbers 28, 35, 40, and 53) and G1 rats. PCR fragments were electrophoresed through a 1-4% agarose gel. M: DNA molecular weight marker phiX174-HaeIII digest or Lambda DNA-HindIII digest.
###end p 56
###begin p 57
(6.28 MB TIF)
###end p 57
###begin p 58
Click here for additional data file.
###end p 58
###begin p 59
###xml 128 132 <span type="species:ncbi:10116">rats</span>
Flow cytometric analysis of bone marrow lymphocyte cells (a) and spleen lymphocyte cells (b) from five-week-old F344 and X-SCID rats. Dot plots represent CD3, CD45RA, and CD161a for discrimination of T-, B-, and NK cell subpopulations; and CD3, CD4, and CD8 for demarcation of T cell subpopulations. The numbers shown in quadrants are mean percentages. Circled areas indicate cell populations referred to in the text.
###end p 59
###begin p 60
(6.66 MB TIF)
###end p 60
###begin p 61
Click here for additional data file.
###end p 61
###begin p 62
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 111 116 111 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 269 274 269 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
Zinc-finger nuclease pairs designed against the Il2rg locus and primer sequences used for PCR analysis for the Il2rg gene. Each exon is underlined. The start codon is indicated by a red box. The three primer sets (small, middle, and large) used for the PCR analysis of Il2rg are shown by boxes. Primers used for the RT-PCR are shown as cDNA.
###end p 62
###begin p 63
(3.32 MB TIF)
###end p 63
###begin p 64
Click here for additional data file.
###end p 64
###begin p 65
Potential zinc-finger nuclease off-target sites.
###end p 65
###begin p 66
(0.14 MB DOC)
###end p 66
###begin p 67
Click here for additional data file.
###end p 67
###begin p 68
###xml 67 71 <span type="species:ncbi:10116">rats</span>
Backcrossing of zinc-finger nuclease-modified founders to F344/Stm rats.
###end p 68
###begin p 69
(0.16 MB DOC)
###end p 69
###begin p 70
Click here for additional data file.
###end p 70
###begin p 71
Intercrossing of zinc-finger nuclease-modified founders between males and females.
###end p 71
###begin p 72
(0.08 MB DOC)
###end p 72
###begin p 73
Click here for additional data file.
###end p 73
###begin p 74
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 54 58 <span type="species:ncbi:10116">rats</span>
Peripheral blood profiles of Il2rg-deficient (X-SCID) rats.
###end p 74
###begin p 75
(0.09 MB DOC)
###end p 75
###begin p 76
Click here for additional data file.
###end p 76
###begin p 77
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il2rg</italic>
###xml 73 77 <span type="species:ncbi:10116">rats</span>
Differential counts of the white blood cells of Il2rg-deficient (X-SCID) rats.
###end p 77
###begin p 78
(0.07 MB DOC)
###end p 78
###begin p 79
Click here for additional data file.
###end p 79
###begin p 80
Primer sequences for zinc-finger nuclease off-target analysis.
###end p 80
###begin p 81
(0.14 MB DOC)
###end p 81
###begin p 82
Click here for additional data file.
###end p 82
###begin p 83
This study was supported in part by a Grant-in-aid for Cancer Research from the Ministry of Health, Labour and Welfare. We thank JL Guenet for critical discussion, and Y Kunihiro, F Tagami, and S Ishida for their assistance with the experiment.
###end p 83
###begin title 84
References
###end title 84
###begin article-title 85
###xml 53 56 <span type="species:ncbi:10116">rat</span>
Germline competent embryonic stem cells derived from rat blastocysts.
###end article-title 85
###begin article-title 86
###xml 47 50 <span type="species:ncbi:10116">rat</span>
Capture of authentic embryonic stem cells from rat blastocysts.
###end article-title 86
###begin article-title 87
###xml 61 64 <span type="species:ncbi:10116">rat</span>
Generation of induced pluripotent stem cell lines from adult rat cells.
###end article-title 87
###begin article-title 88
###xml 14 17 <span type="species:ncbi:10116">rat</span>
###xml 22 27 <span type="species:ncbi:9606">human</span>
Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors.
###end article-title 88
###begin article-title 89
###xml 118 121 <span type="species:ncbi:10116">rat</span>
Pluripotent stem cells and other technologies will eventually open the door for straightforward gene targeting in the rat.
###end article-title 89
###begin article-title 90
###xml 72 77 <span type="species:ncbi:10090">mouse</span>
###xml 82 85 <span type="species:ncbi:10116">rat</span>
Conservation of spermatogonial stem cell self-renewal signaling between mouse and rat.
###end article-title 90
###begin article-title 91
###xml 0 4 <span type="species:ncbi:10116">Rats</span>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Rats produced by interspecies spermatogonial transplantation in mice and in vitro microinsemination.
###end article-title 91
###begin article-title 92
###xml 37 40 <span type="species:ncbi:10116">rat</span>
Transposon-tagged mutagenesis in the rat.
###end article-title 92
###begin article-title 93
###xml 23 27 <span type="species:ncbi:10116">rats</span>
###xml 56 61 <span type="species:ncbi:4932">yeast</span>
Production of knockout rats using ENU mutagenesis and a yeast-based screening assay.
###end article-title 93
###begin article-title 94
###xml 54 68 <span type="species:ncbi:10116">laboratory rat</span>
Generation of gene knockouts and mutant models in the laboratory rat by ENU-driven target-selected mutagenesis.
###end article-title 94
###begin article-title 95
###xml 52 56 <span type="species:ncbi:10116">rats</span>
An ENU-induced mutant archive for gene targeting in rats.
###end article-title 95
###begin article-title 96
###xml 71 74 <span type="species:ncbi:10116">rat</span>
Enhanced colitis-associated colon carcinogenesis in a novel Apc mutant rat.
###end article-title 96
###begin article-title 97
Gene targeting using zinc finger nucleases.
###end article-title 97
###begin article-title 98
Custom-designed zinc finger nucleases: what is next?
###end article-title 98
###begin article-title 99
###xml 53 58 <span type="species:ncbi:9606">human</span>
Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases.
###end article-title 99
###begin article-title 100
###xml 9 13 <span type="species:ncbi:10116">rats</span>
Knockout rats via embryo microinjection of zinc-finger nucleases.
###end article-title 100
###begin article-title 101
###xml 100 106 <span type="species:ncbi:9606">humans</span>
Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans.
###end article-title 101
###begin article-title 102
Cytokines and immunodeficiency diseases.
###end article-title 102
###begin article-title 103
###xml 124 130 <span type="species:ncbi:10090">murine</span>
Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation.
###end article-title 103
###begin article-title 104
###xml 56 62 <span type="species:ncbi:10090">murine</span>
DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect.
###end article-title 104
###begin article-title 105
###xml 34 38 <span type="species:ncbi:10090">mice</span>
Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain.
###end article-title 105
###begin article-title 106
###xml 24 28 <span type="species:ncbi:10090">mice</span>
Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain.
###end article-title 106
###begin article-title 107
###xml 31 35 <span type="species:ncbi:10090">mice</span>
Modulation of hematopoiesis in mice with a truncated mutant of the interleukin-2 receptor gamma chain.
###end article-title 107
###begin article-title 108
###xml 28 33 <span type="species:ncbi:9606">human</span>
Highly efficient endogenous human gene correction using designed zinc-finger nucleases.
###end article-title 108
###begin article-title 109
Targeted manipulation of mammalian genomes using designed zinc finger nucleases.
###end article-title 109
###begin article-title 110
###xml 61 66 <span type="species:ncbi:9606">human</span>
Animal xenograft models for evaluation of gene transfer into human hematopoietic stem cells.
###end article-title 110
###begin article-title 111
###xml 20 25 <span type="species:ncbi:9606">human</span>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
###xml 75 80 <span type="species:ncbi:9606">human</span>
Reconstitution of a human immune system in immunodeficient mice: models of human alloreaction in vivo.
###end article-title 111
###begin article-title 112
###xml 10 14 <span type="species:ncbi:10090">mice</span>
Humanized mice in translational biomedical research.
###end article-title 112
###begin article-title 113
###xml 35 39 <span type="species:ncbi:10090">mice</span>
###xml 71 76 <span type="species:ncbi:10090">mouse</span>
NOD/Shi-scid IL2rgamma(null) (NOG) mice more appropriate for humanized mouse models.
###end article-title 113
###begin article-title 114
###xml 37 42 <span type="species:ncbi:9606">human</span>
Efficient tumour formation by single human melanoma cells.
###end article-title 114
###begin article-title 115
###xml 29 33 <span type="species:ncbi:10090">mice</span>
Higher susceptibility of NOG mice to xenotransplanted tumors.
###end article-title 115
###begin article-title 116
###xml 38 47 <span type="species:ncbi:7955">zebrafish</span>
Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases.
###end article-title 116
###begin article-title 117
Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases.
###end article-title 117
###begin article-title 118
An improved zinc-finger nuclease architecture for highly specific genome editing.
###end article-title 118
###begin p 119
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 119
###begin p 120
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study was supported in part by a grant-in-aid for cancer research from the Ministry of Health, Labour, and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 120

